Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy
ACS Applied Materials & Interfaces · 16.11.2026
DOI: 10.1021/acsami.6c16342 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 16.11.2026. Verfasst von Zijian Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Street, Xi'an710061, China. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disease featured by immune dysregulation, oxidative stress, and an impaired epidermal barrier. Oxidative stress and inflammation establish a self-sustaining vicious cycle that accelerates the progression of atopic dermatitis. However, few naturally derived self-assembled nanohydrogels have been developed to disrupt this reciprocal loop for the treatment of cutaneous AD. In this study, matrine (MAT) and proanthocyanidins (PAC), two Chinese medicine-derived molecules with inherent antioxidant and anti-inflammatory activities, co-assembled spontaneously into nanoparticles (PM NPs) in aqueous solution. Incorporation of PM NPs into the phenylboronic acid-modified carboxymethyl chitosan (CP) crosslinked network enhanced the mechanical strength of carboxymethyl chitosan, forming a composite hydrogel (CPPM). Spectral results verified that PM NP self-assembly was mediated by hydrogen bonding and π-π stacking. CPPM efficiently scavenged reactive oxygen species (ROS), suppressed the activation of the Ox-CaMKII and NF-κB signaling pathways, and activated Nrf2 to restore epidermal redox homeostasis. CPPM exhibited favorable moisturizing capacity, appropriate rheological properties, and mild ROS-triggered release to realize local therapeutic effects. In 1-chloro-2,4-dinitrochlorobenzene (DNCB)-induced AD mice, topical CPPM application significantly alleviated epidermal hyperplasia, itching, and inflammatory cytokine expression without obvious toxicity. This self-assembled bioactive hydrogel can concurrently regulate oxidative stress and inflammatory responses, offering a promising topical therapeutic approach against AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Street, Xi'an710061, China.
- Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Street, Xi'an710061, Shaanxi, China.
ORCID-Profile: Yunhe Zheng, Nan Wang, Ke Wang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Zeng, Z., Meng, J., He, J., Pan, W., Zheng, Y., Xue, Y., Wang, N., & Wang, K. (2026). Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c16342
Vancouver
Zeng Z, Meng J, He J, Pan W, Zheng Y, Xue Y, et al. Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c16342
BibTeX
@article{Zeng2026,
author = {Zeng, Zijian and Meng, Jiahui and He, Jiangchuan and Pan, Weijia and Zheng, Yunhe and Xue, Yanbo and Wang, Nan and Wang, Ke},
title = {Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c16342}
}
EUVIMED